Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001712276-25-000015
Filing Date
2025-12-17
Accepted
2025-12-17 18:34:04
Documents
1
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766014441.html 4  
1 FORM 4 wk-form4_1766014441.xml 4 3321
  Complete submission text file 0001712276-25-000015.txt   4857
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 41 S. RIO GRANDE ST. SALT LAKE CITY UT 84101
Business Address
Taylor Ben R (Reporting) CIK: 0001712276 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 251580710